Vaccine Adjuvants Market on Track for Strong Growth, Estimated to Grow at 9.2% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Vaccine Adjuvants Market Through 2025?
The market for vaccine adjuvants has seen significant expansion in the past few years. The market is predicted to expand from a worth of $1.89 billion in 2024 to a value of $2.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The growth observed during the historic period can be associated with factors such as enhanced vaccine production, the rise of infectious diseases, government driven initiatives and immunization agendas, funds allocated to research and development and the globalization of vaccine dissemination.

What's the Projected Size of the Global Vaccine Adjuvants Market by 2029?
In the forthcoming years, a significant expansion is anticipated in the vaccine adjuvants market. The prediction suggests its growth to "$2.89 billion by 2029 at a compound annual growth rate (CAGR) of 9.2%. The expected growth during the forecasted period is credited to factors such as readiness for pandemics, the broadening vaccine portfolio, international immunization objectives, collaborations and partnerships, and a concentration on therapeutic vaccines. The key trends projected to shape the market include advancements in adjuvant technologies, importance on enhancing immunogenicity, the use of combination adjuvants for increased effectiveness, demand for safer and better-tolerated adjuvants, and the personalization of vaccines and adjuvants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Top Growth Drivers in the Vaccine Adjuvants Industry: What's Accelerating the Market?
The surge in the incidence of infectious diseases is foreseen to drive the expansion of the vaccine adjuvants market in the future. Such diseases are caused by pathogens like viruses, bacteria, fungi, or parasites, which can be treated using vaccines for conditions such as hepatitis B and C, HIV, malaria, syphilis, and brucellosis. For instance, the World Health Organization's 2022 report highlighted that around 10.6 million people worldwide contracted tuberculosis in 2021, resulting in 1.6 million deaths, while 1.5 million people were infected with HIV, causing 650,000 deaths. Hence, the escalating incidence of infectious diseases is a significant catalyst for the growth of the vaccine adjuvants market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

What Trends Will Shape the Vaccine Adjuvants Market Through 2029 and Beyond?
A prominent trend emerging in the vaccine adjuvants market is the prevalence of product innovations. Firms in this market are honing in on the adoption of inventive solutions in order to consolidate their standing. As an example, Evonik Industries, a chemical manufacturing company based in Germany, unveiled PhytoSquene in December 2022. Derived from amaranth oil, this plant-based squalene offers a sustainable alternative to conventional shark-derived squalene. It is intended for utilization in vaccine adjuvants as well as other pharmaceutical applications, augmenting the efficacy of vaccines by amplifying immune responses. The creation of PhytoSquene highlights the growing focus on sustainability within the pharmaceutical industry.

What Are the Main Segments in the Vaccine Adjuvants Market?
The vaccine adjuvants market covered in this report is segmented -

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:
1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions
2) By Pathogen Components: Bacterial Components, Viral Components
3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles
4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems
5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

Which Top Companies are Driving Growth in the Vaccine Adjuvants Market?
Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Which Regions Will Dominate the Vaccine Adjuvants Market Through 2029?
North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.